Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, Executive Chairman of Los Angeles Times, shared a post on X:
“Chemotherapy in bladder cancer lowers lymphocyte counts as shown in a recent approval. A lower lymphocyte count results in increased risk of progression to muscle invasive bladder cancer… chemo even in the bladder has systemic effects. Loss of lymphocytes matter.
It’s called IL15 stimulation of NK and T cells in the bladder . Another name : ANKTIVA ! Our trial results shared with FDA in early bladder cancer showed we accomplish this.”
More from Pat Soon-Shiong on OncoDaily.